Smiths Group sells £70m of ICU Medical shares
Smiths Group
1,625.00p
16:40 26/04/24
1.37%
22.00p
Engineering firm Smiths Group has sold a third of its stake in US-listed IV therapy specialist ICU Medical for £70m.
FTSE 100
8,139.83
17:09 26/04/24
n/a
n/a
FTSE 350
4,470.09
16:59 26/04/24
n/a
n/a
FTSE All-Share
4,423.59
17:14 26/04/24
n/a
n/a
General Industrials
6,846.15
16:59 26/04/24
0.97%
65.89
Smiths, which sold the Smiths Medical division to ICU back in January 2022 for $2.7bn, received $500m-worth of ICU shares as part of the deal. However, the Nasdaq stock has dropped more than 50% since the disposal.
On Friday, the company said it had offloaded 830,000 ICU shares, representing a 3.44% of shareholding and 33% of its own stake.
Smiths said the sale raised $88m which will be used for "general corporate purposes" and will leave the company with a remaining 6.92% stake.